LDN switching could be Costs driven @ ish parliament

[Guest guest]

Come on UK! ...Hot questions lodged 11th December 2003:

http://www.scottish.parliament.uk/business/bb-03/bb-12-12e.htm

S2W-4944 Irene Oldfather: To ask the ish Executive what

information it has in respect of the effectiveness of the use of Low

Dose Naltrexone in the treatment of multiple sclerosis and of current

prescribing practices for Low Dose Naltrexone in the treatment of

multiple sclerosis in (a) Ireland, and ( North America.

S2W-4946 Irene Oldfather: To ask the ish Executive whether it

will consider funding clinical trials to monitor the effectiveness of

Low Dose Naltrexone in the treatment of multiple sclerosis.

S2W-4947 Irene Oldfather: To ask the ish Executive what action

it is taking to ensure that the most effective possible treatments

are provided for people with multiple sclerosis.

S2W-4948 Irene Oldfather: To ask the ish Executive what the

average annual cost for each patient is of prescribing beta

interferon for the treatment of multiple sclerosis.

S2W-4949 Irene Oldfather: To ask the ish Executive what the

estimated annual cost would be for each patient of prescribing Low

Dose Naltrexone for the treatment of multiple sclerosis.